Previous issue | Volume 86 | ESPE2016 | Next issue

55th Annual ESPE

Paris, France
10 Sep 2016 - 12 Sep 2016

Card image cap
Paris, France: 10-12 September 2016 Further information

Poster Presentations

Growth P2

The Influence of Growth Hormone Treatment on the Basal Metabolism in Prepubertal Children with Kabuki Syndrome
aMaastricht University Medical Center, Maastricht, Maastricht, The Netherlands; bZuyderland Medical Center, Heerlen, The Netherlands
hrp0086p2-p642
An Analysis of the Safety of Childhood Growth Hormone (GH) Therapy: Data from the NordiNet® International Outcome Study (IOS)
aKarolinska Institutet and Karolinska University Hospital, Stockholm, Sweden; bSaarland University Medical Centre, Homburg/Saar, Germany; cNovo Nordisk Health Care AG, Zurich, Switzerland; dEpidemiology, Novo Nordisk A/S, Søborg, Denmark; eCharité-University Medicine Berlin, Berlin, Germany
hrp0086p2-p643
Adverse Effects after Priming with Testosterone in Short Statured Boys before Growth Hormone Stimulation Test
aDivision of Paediatric Endocrinoloy, Hospital for Children and Adolescnets, University of Erlangen, Erlangen, Germany; bDivision of Paediatric Urology Endocrinology, Deptartment of Urology, Univiversiry of Erlangen, Erlangen, Germany
hrp0086p2-p644
Metabolic Parameters and Glucose Homeostasis in Childhood Onset Growth Hormone Deficiency at Time of Initial Evaluation and Retesting
Developmental Endocrinology Research Group, Royal Hospital for Children, School of Medicine, University of Glasgow, Glasgow, UK
hrp0086p2-p646
A Case of Hypopituitarism in a Patient with Cantu Syndrome
Health Sciences Department, Anna Meyer Children’s University Hospital, University of Florence, Florence, Italy
hrp0086p2-p649
Delaying Puberty with GnRHa does not Promote Adult Height in GH Treated Children Who Enters Puberty at Average Age
Department of Clinical and Experimental Medicine, Linköping University, SE-58185 Linköping, Sweden
hrp0086p2-p650
Estimation of FGF21 Concentration in Prepubertal Children with Growth Hormone Deficiency before and after 6 Months of Growth Hormone Treatment
aDepartment of Endocrinology and Diabetology, Childrens’ Memorial Health Institute, Warsaw, Poland; bFaculty of Medicine and Health Sciences, University of Jan Kochanowski, Kielce, Poland
hrp0086p2-p651
Abstract unavailable
hrp0086p2-p652
Factors Influencing Peak GH Response During Insulin and Clonidine Stimulation Tests
aEndocrinology Department, University of Medicine and Pharmacy, Tg Mures, Romania; bResearch Methodology Department, University of Medicine and Pharmacy, Tg Mures, Romania; c“CI Parhon” Institute, Bucharest, Romania; dUniversity of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania
hrp0086p2-p655
Improved Growth Outcomes with Jet Delivery of Growth Hormone in Children are Maintained Over Long-Term Treatment
aLondon Centre for Paediatric Endocrinology, Great Ormond Street and University College London Hospitals, London, UK; bFerring Pharmaceuticals, London, UK; cEvicom Ltd, Twickenham, UK; dNottingham University Hospitals NHS Trust, Nottingham, UK
hrp0086p2-p656
Early Diagnosis and Treatment of a Newborn with POU1F1 Mutation
aDivision of Pediatric Endocrinology, Diabetology and Obesity, Department of Pediatric Medicine and Surgery, Centre Hospitalier Universitaire Vaudois (CHUV), Rue du Bugnon 46, 1011 Lausanne, Switzerland; bEndocrinology, Diabetes and Metabolism Service, Centre Hospitalier Universitaire Vaudois (CHUV), Rue du Bugnon 46, 1011 Lausanne, Switzerland
hrp0086p2-p658
Comparison between Effects of Oral Iron and Vitamin A with Oxandrolone upon Height and Puberty of Children with Constitutional Delay of Growth and Puberty
aShahid Beheshti University of Medical Sciences, Tehran, Iran; bPediatric Department, Clinical Research Development Center, Loghman Hakim Hospital, Tehran, Iran
hrp0086p2-p660
'First Do No Harm': Growth Hormone (hGH) Treatment in a Case of Recurrent Craniopharyngioma
aDepartment of Endocrinology, U.M.F. “Grigore. T. Popa” Iasi, Iasi, Romania; bDepartment of Neurosurgery, U.M.F. “Grigore. T. Popa” Iasi, Iasi, Romania
hrp0086p2-p661
A Case of GH Deficiency in a Female with 3M Syndrome
aHealth Sciences Department, University of Florence, Anna Meyer Children’s University Hospital, Florence, Italy; bGenetics and Molecular Medicine Unit, Anna Meyer Children’s University Hospital, Florence, Italy
hrp0086p2-p663
Usefulness of Growth Hormone Transient Treatment Suspension in Prepubertal Children Treated with Growth Hormone
aGermans Trias i Pujol Hospital, Badalona, Spain; bLeo Messi Foundation, Badalona, Spain, cMataró Hospital, Mataró, Spain
hrp0086p2-p666
Birth Length, Weight and Head Circumference of Neonates with IGF-I Receptor Mutations
Schneider Children’s Medical Center, Petah Tikva, Israel
hrp0086p2-p667
A Rare Cause of Growth Delay: Jacobsen Syndrome
“Gr. T. Popa” University of Pharmacy and Medicine, Iasi, Romania
hrp0086p2-p668
A GH-1 Mutation Diagnosed in a Preadolescent Obese Girl with Only Mild Reduced Height
aCHU Nantes, Nantes, Loire-Atlantique, France; bCHU Angers, Angers, Maine-et-Loire, France
hrp0086p2-p669
Long-Term Results of GH Therapy in GH-Deficient Children Treated in Albania
aDivision of Pediatric Endocrinology, Department of Pediatrics, University Hospital Centre “Mother Teresa”, Tirana, Albania; bDepartment of Laboratory, University Hospital Centre “Mother Teresa”, Tirana, Albania
hrp0086p2-p672
Abstract unavailable
hrp0086p2-p673
Did Growth Hormone Treatment Associated with Psychological Status in Children with Short Stature?
Wuhan Medical and Health Center for Women and Children, Wuhan, Hubei Province, China
hrp0086p2-p674
LHX-4 Gene Mutation in a Boy with Hypopituitarism and Severe Congenital Myopathy
aMedical Faculty, University Children’s Hospital, Skopje, Macedonia; bMacedonian Academy of Sciences and Arts, Skopje, Macedonia; cClinic for Endocrinology and Metabolism, Skopje, Macedonia
hrp0086p2-p677
Prevalence and Causes of Short Stature and Impact of GH Therapy among Preschool Children at King Abdul-Aziz Medical City for National Guard in Riyadh, Saudi Arabia
aKing abdulaziz Medical City, Riyadh, Saudi Arabia; bKing Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; cKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia
hrp0086p2-p678
Evaluation of GH Deficient Pre Pubertal Children Treated with Omnitrope® Using the AuxoLog Computer Program
aHospital San Pedro, Logroño, Spain; bHospital Universitario Puerta del Mar, Cádiz, Spain; cHospital Universitario Virgen del Rocío, Sevilla, Spain; dLaboratorio Endocrinología Pediátrica, CIBER Enfermedades Raras, Hospital Vall d’Hebron, Barcelona, Spain; eHospital Universitario Vall d’Hebron, Barcelona, Spain; fSandoz Farmacéutica, Madrid, Spain
hrp0086p2-p681
Calcaneal Apophysitis (Sever's Disease) Development in a Case Using Growth Hormone
Pediatric Endocrinology Clinic, Dr Sami Ulus Obstetrics and Gynecology and Pediatrics Training and Research Hospital, Ankara, Turkey
hrp0086p2-p682
Bone Health Index: A Potential Discriminator between Growth Hormone Deficiency and Constitutional Delay in Growth and Puberty in Adolescent Children
aBharti Vidyapith Medical College and Medical Research Centre, Pune, Maharashtra, India; bAlder Hey Children Hospital, Liverpool, UK
hrp0086p2-p683
Growth Effects of Somatropin during the Treatment Congenital Hypopituitarism in Children after the Start of Puberty
aNWSMU n.a. I.I. Mechnikov, Saint Petersburg, Russia; bChildren’s Endocrinology Center, Saint Petersburg, Russia
hrp0086p2-p684
Congenital Hypopituitarism and Giant Cell Hepatitis in a Two-Months-Old Boy
aSaint-Petersburg State Pediatric Medical University, Saint-Petersburg, Russia; bChildren State Hospital No 1, Saint-Petersburg, Russia
hrp0086p2-p685
Neonatal Characteristics of GH Deficiency in 107 Children
aDepartment of Endocrinology, Bab El Oued Hospital, Algiers, Algeria; bDepartment of Endocrinology, Bologhine Hospital, Algiers, Algeria
hrp0086p2-p686